| Literature DB >> 32675115 |
Gordon Bruce1, Shahzya Chaudhury2, Ben Reynolds2.
Abstract
A 12-year-old boy presented with a prolonged history of headache, fatigue and hypertension. Initial investigations were consistent with presumed non-oliguric end-stage renal disease, leading to a provisional diagnosis of juvenile nephronophthisis. Subsequent imaging demonstrated bilaterally enlarged kidneys without cystic change. Mutation analysis was negative for nephronophthisis, causing diagnostic uncertainty which prompted renal biopsy. Histology revealed a primary renal diffuse large B-cell lymphoma which was highly responsive to chemotherapy, including the anti-CD20 monoclonal agent, rituximab. Renal function improved during lymphoma treatment, with residual chronic kidney disease stage 3a once chemotherapy was completed. Atypical diagnostic features should always prompt re-evaluation of a patient. In this case, the delayed malignancy diagnosis did not have an adverse effect on patient survival or morbidity. The outcome for primary renal lymphoma (PRL) has improved markedly following the introduction of rituximab. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: acute renal failure; chronic renal failure; oncology; paediatric oncology; renal intervention
Mesh:
Substances:
Year: 2020 PMID: 32675115 PMCID: PMC7369147 DOI: 10.1136/bcr-2020-234810
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X